Enable Biosciences

Enable Biosciences Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.2M
Latest Deal Amount
  • Investors
  • 7

Enable Biosciences General Information


Developer of a healthcare technology platform designed to offer ultra-sensitive antibody detection for research and clinical applications. The company's healthcare technology platform develops 1000x more sensitive antibody tests for the early detection and treatment of diseases like Lyme disease and type 1 diabetes, enabling patients to receive early diagnosis and precision monitoring of challenging antibody-associated diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Primary Office
  • 510 Myrtle Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Enable Biosciences Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enable Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2018 $1.2M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator 31-Oct-2017 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 01-Oct-2016 $150K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue

Enable Biosciences Executive Team (4)

Name Title Board Seat Contact Info
David Seftel MD Co-Founder & Chief Executive Officer
Jason Tsai Co-Founder & Chief Technology Officer
Peter Robinson Ph.D Co-Founder & Chief Scientific Officer
Carolyn Bertozzi Ph.D Co-Founder & Chairman, SAB

Enable Biosciences Board Members (1)

Name Representing Role Since
Carolyn Bertozzi Ph.D Self Co-Founder & Chairman, SAB 000 0000

Enable Biosciences Investors (7)

To view Enable Biosciences‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
Diabetes Innovation Challenge Other 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial